FR3031455B1 - Compose derive de l’acide gallique et applications - Google Patents

Compose derive de l’acide gallique et applications Download PDF

Info

Publication number
FR3031455B1
FR3031455B1 FR1550295A FR1550295A FR3031455B1 FR 3031455 B1 FR3031455 B1 FR 3031455B1 FR 1550295 A FR1550295 A FR 1550295A FR 1550295 A FR1550295 A FR 1550295A FR 3031455 B1 FR3031455 B1 FR 3031455B1
Authority
FR
France
Prior art keywords
acid
compound
gallic acid
applications
acid derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1550295A
Other languages
English (en)
Other versions
FR3031455A1 (fr
Inventor
Franck HIMBERT
Philippe Bernard
Francois Xavier Bernard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greenpharma SAS
Bioalternatives SAS
Original Assignee
Greenpharma SAS
Bioalternatives SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greenpharma SAS, Bioalternatives SAS filed Critical Greenpharma SAS
Priority to FR1550295A priority Critical patent/FR3031455B1/fr
Priority to PCT/FR2015/050664 priority patent/WO2015140470A2/fr
Priority to CN201580014439.2A priority patent/CN106456478A/zh
Priority to EP15715346.1A priority patent/EP3119382B1/fr
Priority to US15/127,102 priority patent/US20170112737A1/en
Priority to KR1020167028671A priority patent/KR20160127137A/ko
Publication of FR3031455A1 publication Critical patent/FR3031455A1/fr
Application granted granted Critical
Publication of FR3031455B1 publication Critical patent/FR3031455B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne un composé, un sel de ce composé, un dérivé de ce composé ou un sel de ce dérivé, ledit composé étant choisi parmi l'acide gallique, ses polymères hydrolysables en acide gallique, l'acide hexahydroxydiphénique, ses polymères hydrolysables en acide hexahydroxydiphénique, l'acide ellagique, ses polymères hydrolysables en acide ellagique, les gallotannins, les ellagitannins, et ses applications cosmétiques pour stimuler ou réparer la fonction barrière de l'épiderme et pharmaceutiques pour traiter les lésions provoquées par des pathologies, comme la maladie de Crohn.
FR1550295A 2014-03-18 2015-01-14 Compose derive de l’acide gallique et applications Active FR3031455B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR1550295A FR3031455B1 (fr) 2015-01-14 2015-01-14 Compose derive de l’acide gallique et applications
PCT/FR2015/050664 WO2015140470A2 (fr) 2014-03-18 2015-03-18 Applications cosmétiques et pharmaceutiques de l'acide gallique et de dérivés de l'acide gallique
CN201580014439.2A CN106456478A (zh) 2014-03-18 2015-03-18 没食子酸及其衍生物的化妆品和医药应用
EP15715346.1A EP3119382B1 (fr) 2014-03-18 2015-03-18 Applications cosmetiques et pharmaceutiques de la vescalagine et de la castalagine
US15/127,102 US20170112737A1 (en) 2014-03-18 2015-03-18 Cosmetics and pharmaceutical applications of gallic acid and gallic acid derivatives
KR1020167028671A KR20160127137A (ko) 2014-03-18 2015-03-18 갈산 및 갈산 유도체의 미용학적 및 약제학적 용도

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1550295A FR3031455B1 (fr) 2015-01-14 2015-01-14 Compose derive de l’acide gallique et applications
FR1550295 2015-01-14

Publications (2)

Publication Number Publication Date
FR3031455A1 FR3031455A1 (fr) 2016-07-15
FR3031455B1 true FR3031455B1 (fr) 2019-12-13

Family

ID=53177605

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1550295A Active FR3031455B1 (fr) 2014-03-18 2015-01-14 Compose derive de l’acide gallique et applications

Country Status (1)

Country Link
FR (1) FR3031455B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3117372B1 (fr) 2020-12-15 2023-12-29 Basf Beauty Care Solutions France Sas Utilisations cosmétiques d’un hydrolysat de tourteau d’Hippophae rhamnoides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090103823A (ko) * 2008-03-28 2009-10-01 마루젠세이야쿠 가부시키가이샤 항노화제, 피부외용제 및 음식품
KR101538468B1 (ko) * 2008-11-18 2015-07-23 (주)아모레퍼시픽 7,3',4'-트리하이드록시이소플라본을 함유하는 피부 장벽 강화용 또는 보습용 피부 외용제 조성물
US20100129418A1 (en) * 2008-11-18 2010-05-27 Lowell Jeffry Lawrence Method of inducing negative chemotaxis using an ellagitannin or gallotannin
US20110039796A1 (en) * 2009-04-17 2011-02-17 Zhijun Liu Natural Composition for Anti-Angiogenesis and Anti-Obesity
KR20120091877A (ko) * 2011-02-10 2012-08-20 경상대학교산학협력단 Ｇａｌｌｉｃ ａｃｉｄ를 포함하는 밤 내피 추출물의 항균 항산화성 미백 활성에 의한 피부 개선용 조성물
JP5737663B2 (ja) * 2011-04-22 2015-06-17 大学共同利用機関法人自然科学研究機構 皮膚バリア機能改善剤
KR20120129168A (ko) * 2011-05-19 2012-11-28 한림대학교 산학협력단 카스아리닌을 함유하는 피부 염증질환 예방 및 치료용 조성물
ES2443816B1 (es) * 2012-03-22 2014-12-09 Psoriapiel Salud, S.L. Composición para la prevención y/o el tratamiento de la dermatosis y procedimiento de obtención del mismo
CN104619317A (zh) * 2012-09-21 2015-05-13 雀巢产品技术援助有限公司 用于预防或减少tewl及相关病症和疾病的包含植物酚类的组合物

Also Published As

Publication number Publication date
FR3031455A1 (fr) 2016-07-15

Similar Documents

Publication Publication Date Title
EP3778605A3 (fr) Inhibiteurs de lrrk2 et leurs méthodes de production et d'utilisation
EP4292650A3 (fr) Composés hétérocycliques en tant qu'immunomodulateurs
MA49402A (fr) Polynucléotides aadc pour le traitement de la maladie de parkinson
EA201991399A1 (ru) Аминотриазолопиридиновые соединения и их применение в лечении рака
WO2016073693A3 (fr) Polynucléotides codant pour la dopa décarboxylase et destinés au traitement de la maladie de parkinson
MX2018002402A (es) Compuestos de heteroarilo o arilo biciclicos fusionados como moduladores de la quinasa 4 asociada al receptor de la interleucina 1 (irak4).
EA201890338A1 (ru) Оксадиазольные производные, пригодные в качестве ингибиторов hdac
EP3686200A3 (fr) Composés hétérocycles bicycliques et leurs utilisations en thérapie
EA201691514A1 (ru) Соединения
BR112016015236A8 (pt) composto,composição farmacêutica,uso de um composto,método de inibição e método para tratar ou aliviar a gravidade de uma doença.
MX2018004043A (es) Prevencion, tratamiento y reversion de enfermedad usando cantidades terapeuticamente efectivas de acidos grasos activados.
EA201200473A1 (ru) Замещенные (гетероарилметил)тиогидантоины
WO2015140470A3 (fr) Applications cosmétiques et pharmaceutiques de l'acide gallique et de dérivés de l'acide gallique
TR201908994T4 (tr) Farmasötik bileşimler.
EA201691853A1 (ru) Агонисты мускариновых рецепторов
EA201691141A1 (ru) Соединения против ccr6
WO2016004404A3 (fr) Inhibiteurs de gls1 utiles pour le traitement de maladies
WO2015033228A3 (fr) Composés et leur utilisation pour le traitement du cancer
WO2017117070A8 (fr) Composés deutérés pour le traitement du cancer et de maladies et troubles associés, et compositions et méthodes associées
CA3015494C (fr) Nouvelles compositions et methodes therapeutiques
CL2013000730A1 (es) Proceso para preparar compuestos derivados de dihidropteridinonas, moduladores de la quinasa tipo polo plk-1, útiles para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunes; procesos de preparacion de compuestos intermediarios.
WO2016004413A3 (fr) Inhibiteurs de la gls1 pour le traitement de maladies
EA201692260A1 (ru) Соединения 1,3,4-тиадиазола и их применение в лечении рака
TN2015000356A1 (en) Bicyclic compounds
WO2015059463A3 (fr) Bêta-caténine

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160715

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10